PE02.14LB Functional barriers in the elicitation of broadly neutralizing antibodies against the glycan-V3 site of Env by vaccinationE-posterBroadly neutralizing antibodies
PE02.15LB The near-pan-neutralizing, plasma deconvoluted antibody N49P6 mimics CD4 in its quaternary interactions with the HIV-1 envelope trimerE-posterBroadly neutralizing antibodies
PE02.16LB Improved potency, breadth, and pharmacokinetics of VRC01-class antibodies for HIV-1 prevention and treatmentE-posterBroadly neutralizing antibodies
PE02.17LB A lineage of exceptionally potent and broad BnAbs with ultralong CDRH3 from vaccinated cows focus low-mutation rate from germline into a globular knob contacting the CD4bsE-posterBroadly neutralizing antibodies
PU02.01 Subtle variations in HIV-1 subtype C env sequence features obtained from a slow progressing Indian donor and their association with sensitivity to neutralizing antibodies with distinct epitope specificitiesPublication OnlyBroadly neutralizing antibodies
PU02.03 Isolation of new CAP256-VRC26 lineage members reveals determinants of breadth and potencyPublication OnlyBroadly neutralizing antibodies
OA09.03 Impact of HLA-II associated HIV-1 adaptations on vaccine-induced CD4 T-cell immune responsesOral Abstract SessionCellular immunity
OA09.05LB Spontaneous in vivo control of HIV replication is underpinned by the cross-clade antiviral potency of HIV-specific CD8 T cellsOral Abstract SessionCellular immunity
OA14.05LB Impact of HIV kick-and-kill therapy on host epigenetic and transcriptional programs in PBMC, and viral rebound after cART interruptionOral Abstract SessionCellular immunity
OA20.01 Alternative T cell effector functions are linked to humoral responses to HIV infectionOral Abstract SessionCellular immunity
seek-warrow-warrow-eseek-e101 - 110 of 444 items